ZBH 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-05-01

• In the three-month period ended March 31, 2026, our net sales increased 9.3 percent when compared to the same prior year period. Net sales growth was driven by a combination of our Paragon 28 acquisition, positive effects of changes in foreign currency exchange rates, opportunistic end-of-quarter cu…

• Our net earnings were $238.1 million in the three-month period ended March 31, 2026, compared to $182.0 million in the same prior year period. The increase in net earnings was primarily due to increased net sales, a favorable adjustment of approximately $30 million related to probable U.S. tariff re…

• We expect year-over-year net sales growth of 2.5 percent to 4.5 percent in 2026 to be driven by a combination of market growth, new product introductions, the Paragon 28 acquisition and positive effects of changes in foreign currency exchange rates, partially offset by the expected impact from chang…

• We review sales by two geographies, the United States and International, and by the following product categories: Knees; Hips; S.E.T. (Sports Medicine, Upper Extremities, Foot and Ankle; Trauma, Craniomaxillofacial and Thoracic); and Technology & Data, Bone Cement and Surgical. This sales analysis d…

• The following table presents our net sales by geography and the percentage changes (dollars in millions):

相对上期删除的文字 · 来源:10-Q · 2025-11-05

• Results for the Three and Nine-Month Periods ended September 30, 2025

• In the three and nine-month periods ended September 30, 2025, our net sales increased 9.7 percent and 5.9 percent, respectively, when compared to the same prior year periods. Net sales growth was driven by a combination of our Paragon 28 acquisition, market growth, new product introductions, and low…

• Our net earnings were $230.9 million and $565.8 million in the three and nine-month periods ended September 30, 2025, respectively, compared to $249.1 million and $664.3 million in the same prior year periods. The decreases in earnings were primarily due to the prior year periods featuring a tax ben…

• We expect 2025 full year-over-year revenue growth of 6.7 percent to 7.7 percent in 2025, driven by a combination of Paragon 28 net sales, market growth and new product introductions. We estimate the Paragon 28 acquisition will contribute 2.7 percent to the year-over-year net sales growth. Based on r…

• The ultimate impact that tariffs will have on our net earnings is difficult to predict due to their fluid nature. We account for tariffs as part of the cost of our inventory or instruments and recognize the expense in cost of products sold when the related inventory is sold to a customer, or depreci…

相对上期新增的文字 · 来源:10-Q · 2026-05-01

• limitations, disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of disclosure controls and procedures are met.

• Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporti…

相对上期删除的文字 · 来源:10-Q · 2025-11-05

• Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial rep…